Alzheimer’s, Parkinson’s and Huntington’s disease all belong to the group of amyloid pathologies also called protein misfolding diseases. Since the first discovery of amyloid fibrils of the aggregated protein tau in inclusion of Alzheimer brains samples, research has focussed on how amyloids form and their biological relevance in neurodegenerative diseases. Microfluidics are a well-established tool for the study of protein aggregation in a controllable environment, whereas super-resolution microscopy techniques have been developed and allow imaging protein misfolding in biological models in-vitro e.g. primary neural cell cultures. It was found that during the process of aggregation, misfolded proteins develop variations in toxicity which ca...